《Virology ManualMount Sinai Hospital.doc》由会员分享，可在线阅读，更多相关《Virology ManualMount Sinai Hospital.doc（127页珍藏版）》请在三一办公上搜索。
1、UHN/MSH Microbiology DepartmentPolicy & Procedure ManualPolicy # MI/VIR/01/v12 Page 1 of 2Section: Virology ManualSubject Title: Table of ContentsIssued by: LABORATORY MANAGEROriginal Date: March 14, 2001Approved by:Laboratory DirectorRevision Date: November 8, 2008Annual Review Date: November 8, 20
2、08TABLE OF CONTENTSINTRODUCTION3FLUIDS AND TISSUES SPECIMENS:Cerebral Spinal Fluid (CSF)5Blood/Bone Marrow for CMV Antigenemia46Sterile Fluids33Tissue/Biopsy Specimens41RESPIRATORY TRACT SPECIMENSBroncho-Alveolar Lavage (BAL) - CMV Surveillance (PMH)17Throat/Nasopharyngeal /Nasal Swabs (Symptomatic)
3、19ETT/Auger Suction (Infants)23Bronchoscopy/BAL/Sputum/Washings (Symptomatic)27Throat/Mouth Washings (PMH)31OCULAR SPECIMENS:Ocular Specimens13ORO-FACIAL, GENTIAL AND SKIN LESIONS:Genital/Peri-anal/Mouth/Nose Skin Lesions10GASTINOINTESTIONAL:Faeces/Rectal37URINE:Urine44UHN/MSH Microbiology Departmen
4、tPolicy & Procedure ManualPolicy # MI/VIR/01/v12Page 2 of 2Section: Virology ManualSubject Title: Table of ContentsIssued by: LABORATORY MANAGEROriginal Date: March 14, 2001Approved by:Laboratory DirectorRevision Date: November 8, 2008Annual Review Date: November 8, 2008APPENDICES: Appendix I Reagen
5、ts/Kits 55Appendix II Shell Vial Procedure 58Appendix III Tube Culture (Shell Vials for CPE) Procedure68Appendix IV Indirect Immunofluorescent Antibody (IFA) staining for Viral Culture Confirmation.74 Appendix V Direct Immunofluorescent Antibody (DFA) staining for Viral Culture Confirmation77Appendi
6、x VI Direct Antigen Detection from Specimens81 Appendix VII Hemadsorption of Tube Culture Monolayers 89 Appendix VIII Media 92Appendix X Cryopreservation of Cell Cultures97Appendix XI Recovery of Cryopreserved Cells98Appendix XII Cryopreservation of Virus Isolates99Appendix XIII Preservation of Cell
7、 Culture Monolayers101Appendix XIV Quality Control of Cell Cultures Used for Routine Virus Isolates102Appendix XV Virus Isolation and Identification of Characteristics105Appendix XVI Weekly Work Schedule109Appendix XVII Virology Training Guide112Appendix XVIII Quality Control of Monoclonal Antibodie
8、s113Appendix XIX Pneumocystis Carinii DFA Test117Appendix XX Cytospin Preparation121Appendix XXI Specimens, Cell Lines and Stain Table123Appendix XXII - Sputolysin Procedure 125Record of Edited Revisions126UHN/MSH Microbiology DepartmentPolicy & Procedure ManualPolicy # MI/VIR/02/v03Page 1 of 2Secti
9、on: Virology ManualSubject Title: IntroductionIssued by: LABORATORY MANAGEROriginal Date: March 14, 2001Approved by:Laboratory DirectorRevision Date: May 20, 2005Annual Review Date: November 8, 2008INTRODUCTIONDiagnostic Virology is performed for a variety of reasons, ranging from the diagnosis of a
10、n acute illness to the determination of asymptomatic carrier state.The methods used to diagnose viral infections are based on the fact that many viruses produce characteristic changes in cells of the host and that most of them induce the production of infectious viruses or viral antigens in body tis
11、sues, secretions and excretions. This in turn is usually followed by the production of antibodies, which are specific for the virus and its associated antigens. The many diagnostic procedures used in Diagnostic Virology can be grouped into 4 categories, each with its particular role, limitations and
12、 advantages. These include:I. Microscopic examination of infected tissues and exudates from the patient for evidence of viral inclusions or other pathologic alterations which may be characteristic of certain viruses.II. Isolation (Propagation) and identification of virus from infected tissues or oth
13、er specimens obtained from the patient.III. Serologic studies for detection of virus-specific antibodies or antigens in patients serum. (See Serology Manual).IV. Direct detection of virus, viral antigens or viral nucleic acids (DNA or RNA) in tissues or other specimens from patients, independent of
14、the propagation of these viruses in the laboratory. (eg. Direct Antigen Detection Direct Smear, Centrifugation enhancement, Polymerase Chain Reaction PCR, etc).UHN/MSH Virology Lab is a Containment Level 2* facility that performs or reports the following procedures: 1. Virology Direct Smear: Antigen
15、 Detection done directly on specimens using Cytospin centrifugation and Immunofluorescence staining performed only on cell-containing materials such as Bronco-Alveolar Lavage (BAL), vesicular aspirates and buffy coat. UHN/MSH Microbiology Department Policy & Procedure ManualPolicy # MI/VIR/02/v03Pag
16、e 2 of 2Virology Manual2. Virology PCR:Nucleic Acid Amplification using PCR performed usually on specimens lacking in cellular materials, viable viruses or viral antigens such as CSF and plasma. 3. Virology Shell Vial Assay:Centrifugation-enhanced culture that detects antigens during early stages of
17、 viral propagation. Identification is done by immunofluoresent staining.Many clinically significant viruses can be propagated and detected in appropriately selected cell lines. Certain shell vials (E-mix) can also be modified to performed as a tube culture. These shell vials can detect viruses throu
18、gh cytopathic effect (CPE) and identification is done by immunofluoresent staining.4.Virology Referred Out Tests:Assays that are not performed in this lab, such as Electron Microscopy (EM), are usually sent to the Public Health Laboratory (PHL). EM is done on viruses that cannot be propagated such a
19、s Norwalk, rota and other viruses causing gastro-enteritis. Other viruses requiring EM include BK, JC and Papovavirus.Selection of these assays is driven by the nature of the specimen (eg. type and quantity); seasonality (eg. influenza in winter, enterovirus in summer); information supplied (eg. sus
20、pected viruses, symptoms and the degree of urgency); availability of resources and constrains placed on the laboratory. Samples that are improperly identified; improperly transported or unsafe will not be processed. Specimens containing agents requiring higher than Level 2 Containment* or assays not
21、 available in this lab may be referred to other laboratories for testing. Agents that are transmitted through the air, and can cause serious or life threatening disease (Level 3); viral agents causing haemorrhagic fevers such as the Ebola virus, Marburg virus and Lassa Fever (Level 4) will not be pr
22、ocessed in this laboratory. Refer to Safety Manual or Health Canada web site for Material Safety Data Sheet or a more complete list and Laboratory Biosafety Guidelines http:/www.phac-aspc.gc.ca/msds-ftss/msds36e-eng.phpUHN/MSH Microbiology DepartmentPolicy & Procedure ManualPolicy # MI/VIR/03/v03Pag
23、e 1 of 5Section: Virology ManualSubject Title: Cerebral Spinal Fluid (CSF)Issued by: LABORATORY MANAGEROriginal Date: March 14, 2001Approved by:Laboratory DirectorRevision Date: May 20, 2005Annual Review Date: November 8, 2008CEREBRAL SPINAL FLUID I. IntroductionCerebral Spinal Fluid (CSF) will be r
24、outinely cultured for cytomegalovirus (CMV), herpes simplex virus (HSV), varicella-zoster virus (VZV) and enteroviruses (coxsackie, echo and polio virus). PCR for these viruses will be performed if specifically requested. Other viruses that may be isolated from CSF include mumps virus and adenovirus
25、. Requests for Rubella virus, JC virus, BK virus and arbovirus should be referred to the Public Health Laboratory (PHL).II.Collection and TransportSpecimens should be collected in a clean, sterile container and sent to the laboratory as soon as possible. If a delay in transport or processing is anti
26、cipated, the specimen should be kept at 4oC until processed. If a delay of more than 72 hours is anticipated, the specimen should be frozen at 70oC. Avoid repeated freeze-thaw cycles.III.ProcedureA.Processing of Specimens:Specimens should be set up as soon as possible after arriving in virology labo
27、ratory. After processing, an aliquot of up to 2 mL of the left-over specimen should be stored at -70C in a cryovial.a. If the specimen is requested for PCR and viral culture and i. The amount of specimen is 1.0 mL, perform PCR, tube culture and shell vial assay.UHN/MSH Microbiology Department Policy
28、 & Procedure ManualPolicy # MI/VIR/03/v03Page 2 of 5Virology Manualb.If specimen is requested for viral culture only andiv. The amount of specimen is 0.5mL, perform tube culture and shell vial assay.c.For PCR testing, aliquot 0.2-1 mL first (freeze aliquot unless PCR can be performed immediately) be
29、fore proceeding. A minimum of 0.2 mL is needed for each of PCR and RT-PCR test.d.CSF specimens will be inoculated directly into shell vials without further processing.B. Direct Examination: MethodVirus(es)LocationPCRHSV / CMV / EBV/VZV/ ParvoIn-houseRT-PCR*EnterovirusWest Nile virusIn-house PCRAdeno
30、virusResearch LabPCRHHV6,7Research Lab*RT-PCR = Reverse Transcription PCR using Qiagen Isolation Kit, RealArt reagents and Roche LightCycler. CMV= cytomegalovirus; EBV= Epstein-Barr virus; HSV= Herpes simplex virus; VZV= Varicella-zoster virus; HHV6,7= Human herpes virus types 6,7Note:HSV PCR is rou
31、tinely performed on all CSF requesting virus testing, other PCR and RT-PCR tests are performed only upon request and with approval by a microbiologist. UHN/MSH Microbiology Department Policy & Procedure ManualPolicy # MI/VIR/03/v03Page 3 of 5Virology ManualC. Isolation and Identification:MethodCell
32、Linea Incubation at 36oCStain used/ReadShell VialMRC-5 (if requested)MRC-5 (if requested) 2 days 4 daysCMV-IEVZVShell Vial for CPEE-MixMRC-5 (summer b) 5 days5 daysRead dailyRead dailyaMRC-5 = Human Fibroblast cells b summer = from May to October.D. Interpretation and Processing of Cultures:a) Shell
33、 vial procedure:i) For CMV, fix and stain 1 shell vial after 2 days (or next working day).ii) If VZV is requested, fix and stain 1 shell vial after 4 days (or next working day).See Appendix II for detailed shell vial procedure.b) Shell Vial for CPE should be examined daily for Cytopathic effect (CPE
34、). Any culture demonstrating 2+ or more CPE should be confirmed using appropriate monoclonal antibodies immunofluorescent staining (Refer to Appendices IV and V). If positive, record in freezer program and freeze the cells and supernatant (Refer to Appendix X and XII).UHN/MSH Microbiology Department
35、 Policy & Procedure ManualPolicy # MI/VIR/03/v03Page 4 of 5Virology Manualc) Any culture demonstrating CPE for which a virus cannot be detected using monoclonal antibodies or other in-house methods and toxicity has been ruled out (see below) should be referred to the Public Health Laboratory (PHL) f
36、or electron microscopy and further work-up. Consult the charge/senior technologist or medical microbiologist.d) Culture Toxicity: If toxicity is suspected in a culture (rounding of cells, sloughing of cells, granular cytoplasm of cells or unusual CPE), the cells should be scraped and appropriate mon
37、oclonal antibody staining performed. Negative stain results indicate the need for a passage. Scrape cells and add 0.2 mL of these scraped cells to a fresh tube containing 2 mL of media (1:10 dilution) and proceed again with tube culture method. (Appendix III). If toxicity or CPE persists, refer to t
38、he charge/senior technologist for review. e) Contaminated Culture: If the tube culture is uninterpretable due to bacterial/fungal contamination, replant the specimen. IV.Reporting ResultsPCR:Negative Report:“Negative for _virus. This is a research test”Positive Report*:“POSITIVE for _ virus. This is
39、 a research test.” Indeterminate Report:“Indeterminate by PCR. This is a research test”Shell vial:Negative Report:“Negative for _ virus.”Positive Report*:“POSITIVE for _ virus.”Shell Vial for CPE: Negative Report:“No virus isolated,” Positive Report*:“_ virus isolated” Toxicity Report:Specimen toxic
40、 to cell culture.”Contaminated Report:Specimen is heavily contaminated with bacteria and/or fungus. Unable to perform Virology Culture.”UHN/MSH Microbiology Department Policy & Procedure ManualPolicy # MI/VIR/03/v03Page 5 of 5Virology Manual* Inform senior, charge technologist and/or microbiologist.
41、* Report result to Medical Officer of Health (viral meningitis).* Telephone all positive results to ward/ordering physician and document the calls.* When entering positive results in the Lab Information System (LIS), enter the virus name in the isolate window (under F7). See LIS Manual for entering
42、results.V.References1. Gleaves, Curt A. et al. Cumitech 15A “Lab Diagnosis of Viral Infections”. American Society for Microbiology, August 1994.2. Collier L, Balows A, Sussman M. Topleys and Wilsons Microbiology and Microbial Infections. Volume 1, Ninth Ed. 1998UHN/MSH Microbiology DepartmentPolicy
43、& Procedure ManualPolicy # MI/VIR/04/v03Page 1 of 3Section: Virology ManualSubject Title: Genital/Peri-anal/Mouth/Nose Skin LesionsIssued by: LABORATORY MANAGEROriginal Date: March 14, 2001Approved by:Laboratory DirectorRevision Date: May 20, 2005Annual Review Date: November 8, 2008GENITAL/PERI-ANAL
44、/MOUTH/NOSE/SKIN LESIONSI.IntroductionSpecimens from genital, perianal and oro-labial (mouth/nose) lesions will only be examined for herpes simplex virus (HSV) unless otherwise requested. Specimens from skin lesions will be examined for both herpes simplex virus (HSV) and varicella-zoster virus (VZV
45、). For other viruses requested, refer to Appendix XV (Virus Isolation and Identification) to ensure that the appropriate media is inoculated.II.Collection and TransportThe roof of the vesicle(s) is disrupted. The fluid and cells released from the base of the lesion are collected using a sterile syringe and needle or a sterile swab. If the specimen is collected with a syringe and needle, aspirate viral transport medium into and out of the syringe several times, then express the contents into the viral transport container. Do not
